EUVIMEDEUVIMED entdecken
Crossref

Viability-Based Assessment Reveals True Efficiency of CRISPR-Cas9 Transfection Methods in Rabbit Spermatozoa

Sarah K Topfer, Madi Rutherford, Frances Zewe, Tanja Strive, Kevin P Oh

The CRISPR Journal · 01.04.2026 · 9 (2) · 59-70

DOI: 10.1177/25731599261424870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The CRISPR Journal, online erschienen am 02.04.2026. Verfasst von Sarah K Topfer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Commonwealth Scientific and Industrial Research Organisation (CSIRO), Health & Biosecurity, Acton, Australia. Hauptthemen laut MEDLINE: Spermatozoa, Transfection, CRISPR-Cas Systems, Gene Editing. Die Arbeit nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modern genome editing tools such as CRISPR-Cas9 have revolutionized mammalian genome engineering, yet translation to in vivo applications remains limited by low efficiency and frequent occurrence of mosaicism. Sperm-mediated delivery of editing reagents is one proposed alternative that may mitigate these issues. This method depends on efficient transfection of genome editing materials into viable spermatozoa, a critical yet frequently overlooked parameter. Using FACS, we compared electroporation (Neon NxT) and lipofection (CRISPRMAX) for introducing CRISPR-Cas9 ribonucleoproteins into viable rabbit spermatozoa. Electroporation, shown to enable Cas9 and plasmid transfection in spermatozoa from other species, performed poorly once dead spermatozoa were excluded. In contrast, Lipofectamine CRISPRMAX improved transfection efficiency with minimal effects on spermatozoa viability and motility. These findings emphasize the importance of distinguishing true transfection (transfection of viable spermatozoa) from total transfection and highlight lipofection as a promising alternative to electroporation for sperm-based genome editing, with potential applications in rabbit genome engineering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpermatozoaTransfectionCRISPR-Cas SystemsGene EditingAnimalsMaleRabbitsElectroporationCell SurvivalSperm MotilityLipids

Substanzen

LipofectamineLipids

Autor:innen und Institutionen

  • Commonwealth Scientific and Industrial Research Organisation (CSIRO), Health & Biosecurity, Acton, Australia.

Zitieren

APA

Topfer, S. K., Rutherford, M., Zewe, F., Strive, T., & Oh, K. P. (2026). Viability-Based Assessment Reveals True Efficiency of CRISPR-Cas9 Transfection Methods in Rabbit Spermatozoa. The CRISPR Journal, 9(2), 59-70. https://doi.org/10.1177/25731599261424870

Vancouver

Topfer SK, Rutherford M, Zewe F, Strive T, Oh KP. Viability-Based Assessment Reveals True Efficiency of CRISPR-Cas9 Transfection Methods in Rabbit Spermatozoa. The CRISPR Journal. 2026;9(2):59-70. doi:10.1177/25731599261424870

BibTeX
@article{Topfer2026,
  author = {Topfer, Sarah K and Rutherford, Madi and Zewe, Frances and Strive, Tanja and Oh, Kevin P},
  title = {Viability-Based Assessment Reveals True Efficiency of CRISPR-Cas9 Transfection Methods in Rabbit Spermatozoa},
  journal = {The CRISPR Journal},
  year = {2026},
  volume = {9},
  number = {2},
  pages = {59--70},
  doi = {10.1177/25731599261424870}
}
Kostenlos starten →